Glooko and Dexcom expand diabetes deal
For Glooko, the deal continues an impressive run of form. Earlier this year, it sealed a deal with market expert Novo Nordisk to jointly develop digital diabetes solutions.
Prior to that, it merged with Swedish firm Diasend. The deal expanded its reach to 4,000 diabetes clinics in 23 countries, and its connectivity portfolio to more than 160 different devices.